Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1713 - 1720 of 11617 results
The Untold Story Behind The Design of Mintz with Elkus Manfredi Architects
October 13, 2022| News
California Passes New Law Requiring Physicians and their Employers to Notify Patients about the Open Payments Database
October 11, 2022| Blog| Viewpoint
A Higher Bar: Accelerating Our Commitment to Diversity, Equity, and Inclusion
October 10, 2022| Resources| Viewpoint
An Emerging Split on the Applicability of the Inevitable Disclosure Doctrine Under the DTSA
October 10, 2022| Blog| Viewpoint
Regulatory Roundup: Important FDA Developments at the End of September 2022
October 10, 2022| Blog| Viewpoint
International Comparative Legal Guide – Patents 2023
October 7, 2022| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.